Pharma Reviews: $14 billion loss in 2 years for Indian tycoon shows pharma in real bad shape

India's sprawling generic drug industry has come under increased scrutiny as the US Food and Drug Administration steps up inspections of approved ...
Read more: $14 billion loss in 2 years for Indian tycoon shows pharma in real bad shape